Wanjia Group Holdings Ltd 2025 AR2
The report outlines Wanjia Group Holdings Limited's sustainability performance and financial results for the fiscal year ended March 31, 2025. During the year, the company focused on its core businesses of pharmaceutical wholesale and distribution, and hemodialysis treatment and consultancy services in the PRC. Key highlights include the implementation of energy-saving initiatives, such as signing the Energy Saving Charter 2024, and participating in the Food Wise Charter to support waste reduction. The company also utilized carbon offsets from the Hebei ChengAn Biomass Cogeneration Project to support climate action.
Company: Wanjia Group Holdings Ltd
Sector: Health Care
Country: Hong Kong
Year: 2025
Type: AR2
Pages: 262
Wanjia Group Holdings Ltd
Annual Report
The report outlines Wanjia Group Holdings Limited's sustainability performance and financial results for the fiscal year ended March 31, 2025. During the year, the company focused on its core businesses of pharmaceutical wholesale and distribution, and hemodialysis treatment and consultancy services in the PRC. Key highlights include the implementation of energy-saving initiatives, such as signing the Energy Saving Charter 2024, and participating in the Food Wise Charter to support waste reduction. The company also utilized carbon offsets from the Hebei ChengAn Biomass Cogeneration Project to support climate action.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English, Chinese
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees